Minimizing bias in industry-sponsored outcomes research.
Industry-sponsored research is receiving a considerable amount of attention from public policy makers and private sector decision makers on issues such as bias, objectivity, ethical conduct, and methodological standards. In the case of outcomes research, industry sponsorship often carries the burden of perceived bias and lack of creditability simply because the research has direct, transparent linkages with drug marketing activities. There are, however, widely accepted principles for conducting and assessing good outcomes research, and these should be followed regardless of the funding source and regulatory initiatives.
Freeman
R A
RA
Sterling Winthrop Laboratories, New York 10016.
D015982:Bias; D002986:Clinical Trials as Topic / Q000592:standards*; D016265:Conflict of Interest; D004345:Drug Industry / Q000191:economics / Q000592:standards*; D004991:Ethics, Institutional; D008329:Managed Care Programs / Q000592:standards*; D017063:Outcome Assessment, Health Care / Q000191:economics / Q000592:standards*; D012109:Research Support as Topic; D014481:United States